The belief for years has been that pancreatic tumors were an immune desert because it has too few mutations to flag and too dense a stromal wall to penetrate. This trial suggests the wall can be climbed, if you give the immune system the right map: a personalized neoantigen set, manufactured in weeks, and delivered as mRNA.
You might also like
Without a coherent industrial strategy covering energy, skills, investment, and R and D, we're effectively putting headwinds in front of our most productive exporters rather than giving them a competitive advantage.
Peter Griffin — The Business of Tech
really cool ideas can just naturally make the world better and be commercially successful.
James Bolt — The Business of Tech
for innovation to work in a corporate but has to look and feel like a real startup. It needs its own budget, a clear, finite time span, specific deliverables, and tough stage gates where ideas are reviewed and must earn the right to keep going exactly as they would if a founding team was pitching for the next funding round.
James Bolt — The Business of Tech